TNF and respiratory failure: Ongoing phase II randomized controlled trials (RCTs) of pharmacological therapies targeting calcium release-activated calcium channels and tumor necrosis factor-alpha (TNF-α) aim to prevent further pancreatic necrosis and/or respiratory failure [4].